Onda 4 Mg/5ml (Ondansetron)

Ondansetron, the active ingredient in Onda 4 Mg/5ml, is a 5-HT3 receptor antagonist presented as a 4 mg/5 ml oral solution for parenteral use. It treats and helps prevent nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adults and children. GNH USA supplies Onda 4 Mg/5ml as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Onda 4 Mg/5ml as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ondansetron is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.

- Chemotherapy‑induced nausea and vomiting: Reduces the frequency and severity of vomiting. - Radiation‑induced nausea and vomiting: Helps prevent vomiting during radiation treatment. - Post‑operative post‑treatment post Surgery recovery and post operative nausea: Provides symptom relief after surgical procedures. - Ant the the the … - ...   - ...